Results 161 to 170 of about 14,076 (220)

Biomarkers of standard criteria and marginal donor lungs during ex vivo lung perfusion: A comparative study. [PDF]

JHLT Open
Hu MA, Zhang ZL, Hoffmann RF, Gan CT, Verschuuren EAM, Van De Wauwer C, Leuvenink HGD, Erasmus ME.   +7 more
europepmc   +1 more source

The ELAVL1-PLAUR-suPAR Axis Exacerbates Diabetic Nephropathy by Promoting Podocyte Injury and Inflammation. [PDF]

J Diabetes
Xu D, Xu L, Li L.
europepmc   +1 more source

Systematic functional screening of immunoreceptor tyrosine-based inhibitory motif domains identifies potent inhibitory modules for chimeric antigen receptor-T. [PDF]

Antib Ther
Yang T, Gao M, Sun Y, Li Z, Xie Z, Zou M, Deng M.   +6 more
europepmc   +1 more source

Select novel small-molecule uPA potential inhibitors as anti-cancer agents against breast cancer. [PDF]

Sci Rep
Almosnid N, Islam I, Ali R, Algheribe S, O Al-Kaysi R, Huwaizi S, Abed RA, Aldeghaither D, Boudjelal M, Samman N, Mehyar N, Alruwaili N.   +11 more
europepmc   +1 more source

Editorial: Advancements in bioactive nanomaterials for disease management. [PDF]

Front Pharmacol
Liu P, Wu J, Hsu JC.
europepmc   +1 more source

Anti-uPAR CAR T cells reverse and prevent aging-associated defects in intestinal regeneration and fitness. [PDF]

Nat Aging
Eskiocak O, Gewolb J, Shah V, Rouse JA, Chowdhury S, Akyildiz EO, Fernández-Maestre I, Boyer JA, Filliol A, Harris AS, Utama R, Guo G, Castro-Hernández C, Nnuji-John E, Chung C, Anderson A, Flowers S, Habel J, Romesser PB, Levine RL, Lowe SW, Sadelain M, Beyaz S, Amor C.   +23 more
europepmc   +1 more source

Advances in Targeted Toxin Therapy for Malignant Gliomas: A Narrative Review. [PDF]

Toxins (Basel)
Polavarapu H, Hall WA.
europepmc   +1 more source

Optimizing uPAR-targeting radiopeptides for improved tissue distribution: progress towards radionuclide therapy. [PDF]

Eur J Nucl Med Mol Imaging
Vaccarin C, Beyer D, Schmid JV, Klein B, Jegathasan J, Behera S, Deupi X, Schibli R, Müller C.   +8 more
europepmc   +1 more source

Virus-derived serpin reduces immuno-coagulopathic damage in murine colitis by targeting the urokinase-type plasminogen activator receptor (uPAR) and complement. [PDF]

Sci Rep
Lucas AR, Monder H, Enow J, Woodrow C, Spaccarelli L, Garg A, Schlievert J, Elmadbouly N, Dupati A, Aliskevich E, Saju R, Kilbourne J, Lowe K, Hamada M, Pinteric A, Zanetti IR, Satyanarayanan RS, Gisriel S, Florsheim EB, Rahman M, Irving J, McFadden G, Kong W, Zhang L.   +23 more
europepmc   +1 more source

The Urokinase-Type Plasminogen Activator Receptor (uPAR) as a Mediator of Physiological and Pathological Processes: Potential Therapeutic Strategies. [PDF]

Cancers (Basel)
Iftikhar A, Mahmood N, Rabbani SA.
europepmc   +1 more source